SBRT 2016

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Chang Lancet Oncol 2015

 Higher rates of adverse events after surgery  No significant differences in recurrence pattern  (Improved) at least equivalent OS

/ Matthias Guckenberger - SBRT for stage I NSCLC

50